REVIEW Open Access

REVIEW Open Access

Caffarelli et al. Italian Journal of Pediatrics (2018) 44:82 https://doi.org/10.1186/s13052-018-0524-7 REVIEW Open Access Advances in pediatrics in 2017: current practices and challenges in allergy, endocrinology, gastroenterology, genetics, immunology, infectious diseases, neonatology, nephrology, neurology, pulmonology from the perspective of Italian Journal of Pediatrics Carlo Caffarelli1*, Francesca Santamaria2, Dora Di Mauro1, Carla Mastrorilli1, Silvia Montella2, Bertrand Tchana3, Giuliana Valerio4, Alberto Verrotti5, Mariella Valenzise6, Sergio Bernasconi7 and Giovanni Corsello8 Abstract This review provides an overview of a remarkable number of significant studies in pediatrics that have been published over the past year in the Italian Journal of Pediatrics. We have selected information from papers presented in the Journal that deal with allergy, endocrinology, gastroenterology, genetics, immunology, infectious diseases, neonatology, nephrology, neurology, pulmonology. The relevant epidemiologic findings, and developments in prevention, diagnosis and treatment of the last year have been discussed and placed in context. We think that advances achieved in 2017 will help readers to make the future of patients better. Keywords: Allergy, Endocrinology, Gastroenterology, Genetics, Immunology, Infectious diseases, Neonatology, Nephrology, Neurology Pediatrics, Pulmonology Background Review A remarkable number of papers that may have a signifi- Allergy and immunology cant impact on the management of different childhood 1-diagnosis of cow’s milk allergy; 2 -corticosteroids in diseases, have been issued in Italian Journal of Pediatrics atopic dermatitis; 3-innovative treatments for allergic in 2017. This review highlights the most accessed arti- diseases; 4-ANCA-associated vasculitis cles and it puts them in the specific context. We have Clinical features of immediate IgE-mediated reactions covered a choice of articles on allergy, endocrinology, [1] triggered by cow’s milk include skin symptoms (rash, gastroenterology, genetics, immunology, infectious dis- angioedema, urticaria) [2], nausea, vomiting, abdominal eases, neonatology, nephrology, neurology, pulmonology pain, diarrhea, rhinoconjunctivitis, asthma, anaphylaxis. in childhood. The diagnosis of cow’s milk allergy is based on a convin- cing history and positive IgE tests (skin prick tests (SPTs) and/or serum specific IgE antibodies [3]), but the gold standard is a positive oral food challenge [4]). A systematic review [5] has addressed the utility of SPT or * Correspondence: [email protected] ’ 1Clinica Pediatrica, Department of Medicine and Surgery, Azienda IgE cut-off values for avoiding cow s milk challenge. In Ospedaliera-Universitaria, University of Parma, Parma, Italy children < 2 years of age, an IgE cut-off point of 5 kU/L Full list of author information is available at the end of the article © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Caffarelli et al. Italian Journal of Pediatrics (2018) 44:82 Page 2 of 17 and SPT cut-offs for weal diameter > 6 mm for commer- refurbishing T regs [17]. Moreover, probiotics downregu- cial extract and > 8 mm for fresh milk were found. No late Th2 cytokines in allergic rhinitis. [18]. Probiotics may cut-off values were found to predict allergy to fresh also prevent mucosal damage induced by hydrogen perox- cow’s milk and baked milk in children > 2 years of age. ide [19] which is increased during exacerbations of Cut-off values of IgE tests are affected not only by age respiratory allergy [20]. Del Giudice et al. [21]showedthat but also by several factors such as studied population, aBifidobacteriamixture,Blongum, Binfantisand B breve, clinical picture, time of investigation, methods of IgE significantly reduced nasal symptom score and improve testing. So, it is advisable that reliable cut-off values quality of life in children with parietaria-induced allergic should be set up by each allergist using data from his rhinitis and was well tolerated. This investigation supports laboratory. Patch test to cow’s milk is not useful [6]. earlier observations of a possible benefit of adjuvant ther- Many efforts have been dedicated to improve the treat- apy with probiotics in seasonal allergic rhinitis [22]. ment of atopic diseases. The pharmacological first-line Data on anti-neutrophil cytoplasmic antibody treatment for atopic dermatitis is based on topical corti- (ANCA)-associated vasculitis (AVA) are scarce in child- costeroids (TCS) [7], even if a systemic inflammatory hood perhaps due to rarity in pediatric age, 0.5–6 new response is often present [8]. Poor adherence and lack of cases /million children/year, in comparison with adult- effectiveness of treatment is commonly caused by steroid hood, but possibly also due to lack of clinical studies and fear [9]. By using a questionnaire, El Hachem M. et al. investigations on natural history. With this in mind, [10] investigated “corticophobia” in families of 300 pa- Calatroni’s overview of childhood-onset AVA is relevant tients. Eighty-one percent of the respondents reported [23]. Fever, fatigue, anorexia, and weight loss precede to be afraid of TCS. Most care givers were concerned systemic manifestations. So, early diagnosis is difficult. that danger of TCS was not related to side effect and In microscopic polyangiitis (MPA), prognosis mainly that receives help from treatment do not overcome depends on renal symptoms that are present in almost detriments. There was also fear to incorrectly apply an all cases at onset of disease, and on lung manifestations. excessive quantity of cream. The result of this study Granulomatosis with polyangiitis (GPA, formerly Wege- highlights the need for age related educational programs ner’s granulomatosis) [24] is characterized by ear, nose for the control of atopic dermatitis. Such programs have and throat manifestations. Involvement of kidney and been shown to be effective in ameliorating the disease lower respiratory tract is less frequent. Clinical pheno- [11] and in improving the quality of life of eczematous types in childhood and adulthood are similar. However, children [12]. at variance from adults, children frequently present sub- Allergen-specific immunotherapy (AIT) is considered glottic stenosis and saddle nose deformity, while periph- the only causal disease-modifying treatment for allergic eral neuropathy and cardiovascular involvement are rare. disorders. Among the 2017 highlights is a consensus Eosinophilic granulomatosis with polyangiitis (EGPA, [13] that provides recommendations for use of AIT in formerly Churg-Strauss syndrome) usually starts with practice. This consensus emphasized that selection of asthma, allergic rhinitis, and sinusitis. Later features are patients and schedule of administration are a crucial hypereosinophilia with nasal polyps, and lung infiltrates, issue for efficacy of AIT. In children with allergic rhinitis and vasculitis with urticarial rash and purpura, and car- and allergic asthma, both subcutaneous and sublingual diovascular, musculoskeletal, gastrointestinal, neurologic, AIT have very good efficacy and safety. Furthermore, in and renal manifestations. ANCA positivity is reported in children with rhinoconjunctivitis due to grass allergy, 50–60% of children with MPA and GPA but only in 25% AIT is useful for reducing the risk for asthma develop- of children with EGPA. Children are treated with gluco- ment. However, it is unclear whether it may reduce the corticosteroids plus cyclophosphamide as with adults onset of pollen-food syndrome that is a frequent result [25]. Rituximab is for non-responsive or relapsing chil- of cross-reactivity between pollen allergens and food dren. Other options are mycophenolate, methotrexate, allergens with similar structure [14]. It should be under- and plasma exchange. Maintenance treatment includes lined that choice of airborne allergens for AIT should be azathioprine, low-dose rituximab or mycophenolate. based on diagnosis of sensitization to relevant genuine Mortality rate is 5–10% in children and it is lower than molecules rather than to panallergens [15]. Subcutane- in adults [26]. ous AIT is recommended for allergy to hymenoptera venom. Oral AIT has shown to be a promising treatment Endocrinology for IgE-mediated food allergy while there are contrasting 1-obesity; 2-Suclinical hypothyroidism data on the role of AIT in atopic dermatitis [16]. Pediatric obesity is associated with multiple physical and Another area of research has been the treatment of psychosocial co-morbidities [27–29] and with premature allergic rhinitis with probiotics. Probiotics may change morbidity and mortality for metabolic disease and cardio- immune function by upregulating Th1 pathway and vascular events, which are the leading cause of mortality Caffarelli et al. Italian Journal of Pediatrics (2018) 44:82 Page 3 of 17 in the industrialized countries [30–32]. A few studies ana- migraine that non-obese individuals and that obesity is

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    17 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us